Polycationic calcium modulator peptides for the treatment of hyperparathyroidism and hypercalcemic disorders
US8987200B2 · kind B2 · utility
8Cited by
17References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 16, 2007 |
| Grant date | Mar 24, 2015 |
| Priority date | — |
| Expiry date | Dec 22, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods and kits for treating hyperparathyroidism, bone disease and/or hypercalcemic disorders. In particular, methods for lowering serum PTH and serum calcium using polycationic calcium modulator peptides are provided. The calcium modulator peptides can be used to treat subjects having, for example: primary, secondary or tertiary hyperparathyroidism; hypercalcemia of malignancy; metastatic bone disease; or osteoporosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.